Skip to main content

Table 1 Subject disposition

From: Long-term effect of latanoprost/timolol fixed combination in patients with glaucoma or ocular hypertension: A prospective, observational, noninterventional study

 

No. (%) subjects

Received latanoprost/timolol FC

2339

   Completed 24 months of follow-up

1317 (56.3)

   Discontinued prior to 24 months

1022 (43.7)

Per protocol population

   Included

1028 (44.0)

   Excluded

1311 (66.0)

Reason(s) for exclusion:*

Not treated for ≥18 months

512

No baseline and ≥1 postbaseline measure for IOP ≥18 months apart

487

Additional ocular hypotensive medication during study

402

Ametropy at baseline

42

Full analysis set

   Included

1934 (82.7)

   Excluded (no postbaseline IOP measurement)

405 (17.3)

Safety population

2339 (100.0)

  1. FC = fixed combination; IOP = intraocular pressure.
  2. *More than one reason was possible. If a subject was excluded from the full analysis set, a separate reason for exclusion from the per protocol population is not provided in this table.